Search Results
Clot Chronicles: The MARINER Trial Results
Clot Chronicles: The MARINER Trial with Dr. James Welker
Clot Chronicles: PAD Management-Key Insights from the VOYAGER PAD Trial
Alok A. Khorana: Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients
MAGELLAN Trial Review and the Risk of Bleeding
The APEX Trial: Full vs Reduced Doses of Betrixaban
NOACs for the Medically Ill and Risk of Extended Prophylaxis
Defining Medically Ill Patients for VTE Prophylaxis
ESC: Rivaroxaban Doesn't Prevent VTE after Acute Illness - Medpage Today
Turning the Tide on Venous Thromboembolism
Alex Spyropoulos, Professor of Medicine, the Zucker School of Medicine at Hofstra/Northwell, USA
ACC.11 | MAGELLAN Trial
